PDE4 as a target for cognition enhancement

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.17, Iss.9, 2013-09, pp. : 1011-1027

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PDE Inhibition and cognition enhancement

By Blokland Arjan Menniti Frank S Prickaerts Jos

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 4, 2012-04 ,pp. : 349-354

Informa Healthcare

Access to resources Recommend Favorite

Selective phosphodiesterase inhibitors: a promising target for cognition enhancement

By Reneerkens Olga Rutten Kris Steinbusch Harry Blokland Arjan Prickaerts Jos

Psychopharmacology, Vol. 202, Iss. 1-3, 2009-01 ,pp. : 419-443

Springer Publishing Company

Access to resources Recommend Favorite

Phosphodiesterase Inhibitors as a Target for Cognition Enhancement in Aging and Alzheimer’s Disease: A Translational Overview

Current Pharmaceutical Design, Vol. 21, Iss. 3, 2015-01 ,pp. : 317-331

Bentham Science Publishers

Access to resources Recommend Favorite

PDE4 inhibitors 1998

By Norman P.

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 7, 1998-07 ,pp. : 771-784

Informa Healthcare

Access to resources Recommend Favorite

PDE4 inhibitors 1999

By Norman P.

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 8, 1999-08 ,pp. : 1101-1118

Informa Healthcare

Access to resources Recommend Favorite